- INNOVATION • ACCURACY • EXPERTISE • SPEED
Specialty Diagnostics for the Most Critical Patients
Your Partner in Improving Health Outcomes
- INNOVATION • ACCURACY • EXPERTISE • SPEED
Your Trusted Laboratory Partner Dedicated to Improving Health Outcomes
GET RESULTS FASTER. WHEN IT MATTERS MOST
- INNOVATION • ACCURACY • EXPERTISE • SPEED
Access To Complete Diagnostics Has Never Been Easier
testing for life
- INNOVATION • ACCURACY • EXPERTISE • SPEED
Hybrid-capture Next Generation Sequencing
Comprehensive Pathogen Detection • Increased Sensitivity and Specificity • Simultaneous Detection of Multiple Pathogens
- INNOVATION • ACCURACY • EXPERTISE • SPEED
The ExPeCT anti-CD19 (FMC63) CAR T Assay
directly monitor CAR T-cell therapy
- INFECTIOUS DISEASE • ONCOLOGY• IMMUNOLOGY • ALLERGY/HYPERSENSITIVITY
Developing, Customizing and Validating Assays for Complex Clinical Research Testing
THERAPEUTICS • VACCINES • CELL AND GENE THERAPIES
Innovations in Testing
All of our assays are designed to enhance diagnostic accuracy and improve patient outcomes. Our latest innovations include ExPeCT™ anti-CD19 CAR T, a breakthrough in assessing CAR T cell therapy efficacy, and NeXGen™ Fungal / AFB NGS, which offers advanced next-generation sequencing...
Who is Eurofins Viracor?
At Eurofins Viracor, we’ve spent over 40 years delivering trusted diagnostic solutions for critically ill and immunocompromised patients. We specialize in infectious disease, immunology, transplant, and allergy. Trust our expertise for accurate results, exceptional turnaround times, and personalized guidance that helps you make confident decisions in patient care.
Explore the Test Menu
We offer a comprehensive up-to-date test menu with nearly 3000 assays, including information on accepted specimen types, collection instructions, shipping details and more. With advanced technology and expertise in molecular diagnostics and immunology, expect highly accurate, reliable results.
Get Results Faster, When It Matters Most
When you work with us, you're accessing over 40 years of diagnostic innovation and specialized expertise in infectious disease, pre- and post-transplant, allergy, invasive fungals, and immunology testing for immunocompromised and critical patients — plus a menu of over 3000 assays.
We are passionate about providing timely, actionable diagnostic information — never losing sight of the connection between the testing we perform and the patients you serve.
Clinical diagnostic laboratory testing plays a crucial role in improving patients' lives by providing accurate and timely diagnosis of various diseases. It helps physicians make informed decisions about treatment plans and monitor disease progression.
By detecting diseases at an early stage, laboratory testing can also increase the likelihood of successful treatment outcomes and improve overall patient health. Let's improve outcomes together. Explore our test menu.
SET UP AN ACCOUNT
We Want To Be Your Clinical Lab Partner.
Let's Get You Started.
Account Setup
INNOVATION
2500+
available tests and
counting
ACCURACY
CAP
Accreditation
CLIA
Certified
AGILITY
75%
of transplant
programs across
the U.S. trust us
with their critical
testing
EXPERTISE
40+
years of diagnostic
innovation
SPEED
TAT
Infectious Disease
testing results in
the same day
(8-12 hours from
specimen receipt)
Featured News
Eurofins Viracor Launches ExPeCT™ anti-CD19 (obe-cel) CAR T-Cell Assay to Advance Proactive Monitoring in Next-Generation Immunotherapy
Eurofins Viracor has launched the ExPeCT™ anti-CD19 (obe-cel) CAR T-cell assay, a new diagnostic solution designed to support proactive monitoring of next-generation CAR T-cell therapies. This non-invasive blood test enables real-time assessment of CAR T-cell expansion and persistence, delivering results in approximately 24 hours after specimen receipt. Developed specifically for testing obecabtagene autoleucel (obe-cel), the assay helps clinicians gain timely, validated insights to support informed therapy decisions.
News & Events
Eurofins Viracor Launches Assays for Pneumococcal Antibody Detection, Expanding Serotype Coverage to Support Immunocompromised Patient Care
Eurofins Viracor has launched multiplex pneumococcal antibody assays covering all vaccine serotypes, including PCV21. The 32‑serotype panel improves accuracy and supports personalized immunity monitoring. This advancement reinforces the company’s leadership in immunology diagnostics.
Eurofins Viracor Revolutionizes Respiratory Diagnostics with New BAL Specimen Type for NeXGen® Fungal / AFB NGS Assay
At Eurofins Viracor, we’re advancing respiratory infection diagnostics with the introduction of a bronchoalveolar lavage (BAL) specimen type for our NeXGen® Fungal / Acid Fast Bacteria (AFB) NGS assay...
Revolutionizing Fungal Diagnostics: Why qPCR Is a Game-Changer for Dimorphic Fungal Infections
We're advancing the fight against invasive fungal infections with quantitative PCR (qPCR), a powerful diagnostic tool that delivers rapid, sensitive, and specific detection of Blastomyces, Histoplasma, Coccidioides, and Cryptococcus species. Traditional methods like culture and serology often delay diagnosis, but qPCR enables us to detect fungal DNA directly from BAL, CSF, and sputum within hours...